Unlock instant, AI-driven research and patent intelligence for your innovation.

SFRP2 methylation detection kit and application thereof

A detection kit and methylation technology, applied in the field of SFRP2 methylation detection kits, can solve the problems of reducing sample complexity, small number of DNA samples, PCR amplification failure, etc. False positive problem, the effect of improving detection specificity

Pending Publication Date: 2022-07-08
SHANGHAI HEALZONE BIOTECHNOLOGY CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, the bisulfite conversion method also has many shortcomings: (1) bisulfite sequencing needs to ensure that the bisulfite conversion reaction is complete, that is, every unmethylated cytosine is converted into uracil, if If the transformation reaction is not complete, false positive results will appear; (2) Since only cytosine of single-stranded DNA can be attacked by bisulfite, the DNA needs to be denatured and melted before transformation, and factors such as temperature and salt concentration must be strictly controlled , otherwise it will cause conversion failure or incomplete conversion; (3) DNA may be degraded during the conversion reaction, if the incubation time is too long, the temperature and bisulfite concentration are too high, it may cause up to 90% of the DNA to be degraded , depurinated DNA after degradation forms random breaks, which may lead to PCR amplification failure or small number of DNA samples, low accuracy, and then false negative detection; (4) bisulfite treatment will significantly reduce the complexity of the sample, making Multiplex PCR primer design is more difficult and errors increase

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • SFRP2 methylation detection kit and application thereof
  • SFRP2 methylation detection kit and application thereof
  • SFRP2 methylation detection kit and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] Example 1 Detection of methylated DNA of human SFRP2 gene

[0075] In this example, methyltransferase-treated Jurkat DNA was used as a positive standard for methylation of human SFRP2 gene, and nuclease-free water was used as a negative control, wherein the CG site was 5mCG, and the methylation site of SFRP2 gene was detected. Proceed as follows:

[0076] (1) Methylation-dependent restriction endonuclease GlaI was used to digest the positive standard and negative control. The reaction system was 2 μL of 10× digestion buffer, 5U GlaI, and different concentrations of genomic DNA, and the total system was 20 μL ; The reaction conditions were incubated at 30°C for 1 hour; after the enzyme cleavage reaction, the system was heated to 85°C and incubated for 10 minutes to heat inactivate GlaI;

[0077] (2) Add SFRP2 gene capture oligonucleotides, universal primers, specific primers and detection probes to the above enzyme digestion reaction system respectively, and PCR detects...

Embodiment 2

[0089] Example 2 Amplification results of 2'-Fluoro RNA modification in the folded region of captured oligonucleotides

[0090]Due to the limitations of the existing oligonucleotide synthesis technology, the capture oligonucleotide may produce by-products with incomplete sequence fragments during the synthesis process, which may cause non-specificity in the high concentration of non-methylated background. Amplification, in this example, by modifying the 2'-Fluoro RNA in the folded region of the capture oligonucleotide, the non-specific amplification caused by the residual fragments is effectively suppressed, and the detection specificity is improved.

[0091] The positive templates, universal primers, specific primers, detection probes and reaction conditions used in this example are the same as in Example 1, and the capture oligonucleotides used include:

[0092] 2'-Fluoro RNA modified capture oligonucleotide (SEQ ID NO:6):

[0093] 5-TGTCAGCCAACGGTATTCATCTTTGCGACCC CGAGGG...

Embodiment 3

[0095] Example 3 Methylation detection of human SFRP2 gene in stool samples

[0096] In this example, the methyltransferase-treated Jurkat DNA was used as the positive standard for methylation of the human SFRP2 gene, and the CG site was 5mCG, which was incorporated into the DNA of the stool sample to detect the methylation site of the SFRP2 gene. Nuclease-free water was used as a no-template control. Proceed as follows:

[0097] (1) Methylation-dependent restriction endonuclease GlaI was used to digest the mixed sample and no-template control. The reaction system was 1× PCR buffer (purchased from Nanjing Novizan, P122-d1), 5U GlaI 10 μL of genomic DNA with different concentrations; the reaction conditions were incubation at 37°C for 1 hour; after the digestion reaction, the system was heated to 85°C and incubated for 10 minutes to heat inactivate GlaI;

[0098] (2) Add SFRP2 gene capture oligonucleotide (SEQ ID NO:6), universal primer (SEQ ID NO:2), specific primer (SEQ ID ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an SFRP2 methylation detection kit and application thereof. The kit comprises methylation dependent restriction endonuclease, capture oligonucleotide and a universal primer, the capture oligonucleotide sequentially comprises a first universal sequence, a folding sequence and a binding capture sequence from the 5'end to the 3 'end; the folding sequence is at least partially the same as a 5'terminal sequence after the SFRP2 methylation site is subjected to enzyme digestion by methylation dependent restriction endonuclease; the binding capture sequence is specifically bound with a fragment region where the detected SFRP2 methylation site is located. Based on methylation dependent restriction endonuclease and a universal primer fluorescent quantitative PCR technology, conversion of bisulfite is not needed, and accurate and specific SFRP2 methylation detection is achieved.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to an SFRP2 methylation detection kit and application thereof. Background technique [0002] Colorectal cancer (CRC) is a common malignant tumor of the gastrointestinal tract. With the change of people's living habits, the incidence and mortality of colorectal cancer have increased significantly, which is a serious threat to human health. The symptoms of colorectal cancer are not obvious in the early stage. As the tumor enlarges, it shows symptoms such as changes in bowel habits, blood in the stool, diarrhea, alternating diarrhea and constipation, and local abdominal pain. In the advanced stage, it develops into systemic symptoms such as anemia and weight loss. [0003] Currently, fecal occult blood test (FOBT) and colonoscopy are mainly used for colorectal cancer screening. As a routine screening method, FOBT is susceptible to the influence of food, drugs and other factors, with a high ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12Q1/686C12N15/11
CPCC12Q1/6886C12Q1/686C12Q2600/154C12Q2563/107C12Q2545/114
Inventor 徐宏杨浩徐高连古宏晨
Owner SHANGHAI HEALZONE BIOTECHNOLOGY CO LTD